Main objective: To study the level of (proneness to) shame among patients with a borderline personality disorder following MBT at a general mental health institution in the south of the Netherlands (GGz Breburg) at the start of treatment as well as…
ID
Source
Brief title
Condition
- Personality disorders and disturbances in behaviour
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
(Proneness to) shame:
Since shame can reflect an emotion that may not be consciously accessible to
the patient, shame(-proneness) will be measured not only on a self-report level
(assessed by the Compass of Shame Scale, a self-report questionnaire), but on a
more implicit level (assessed by the Implicit Association Test, a computer
based paradigm) as well.
Secondary outcome
Measurements associated with the general treatment goals of MBT:
Measurements of levels of symptom distress, social and interpersonal
functioning, personality pathology and functioning, and number of suicide
attempts, acts of self-harm
Background summary
Proneness to shame (i.e. the tendency to experience shame in various
situations) is thought to be linked with core borderline personality disorder
(BPD) symptoms including chronic suicidality, self harm, impulsivity, and
inappropriate anger. Recognizing the impact of intense and chronic shame, and
helping persons with BPD to reduce or regulate aversive states of shame may
contribute to successful psychotherapeutic treatment. With respect to
Mentalization-Based Treatment (MBT), a 18-month treatment program developed for
patients with borderline personality pathology, it can be hypothesized that
MBT fosters recognizing feelings of shame and changing maladaptive shame into
more adaptive shame regulation during treatment. However, empirical evidence
about proneness to shame among patients with borderline personality pathology
at the start of MBT and during MBT is as yet not available.
Study objective
Main objective:
To study the level of (proneness to) shame among patients with a borderline
personality disorder following MBT at a general mental health institution in
the south of the Netherlands (GGz Breburg) at the start of treatment as well as
during treatment (primary objective)
Secondary objectives:
Cross-sectional: To study associations between shame and indicators of
(borderline personality) pathology (symptom distress, personality functioning,
social and interpersonal functioning, acts of self-harm and suicide attempts).
Longitudinal: To study during MBT the level of improvement regarding level of
symptom distress, social and interpersonal functioning, personality pathology
and functioning, and number of suicide attempts, acts of self-harm
Study design
Longitudinal; prospective cohort study
Study burden and risks
Patients will be interviewed and self-report questionnaires and a computer task
will be administered before treatment and every three months during treatment,
i.e. after 3, 6, 9, 12, 15 and 18 months after the start of treatment. Except
for the IAT computer task, all measurements are part of diagnostic and routine
outcome monitoring at the start of MBT and during MBT. Maximum duration for the
IAT assessments is 105 minutes (7 measurements * maximum duration of 15 minutes
for each IAT).
Professor Cobbenhagenlaan 125
Tilburg 5037 DB
NL
Professor Cobbenhagenlaan 125
Tilburg 5037 DB
NL
Listed location countries
Age
Inclusion criteria
Borderline personality disorder
Referred to MBT
Exclusion criteria
Refusal to take part in scientific studies
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL52382.028.15 |